Meibomian gland dysfunction
Conditions
Interventions
Sponsors
Inouye Eye Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Over 20years old 2. Male and Female 3. Patients diagnosed as dry eye 4. Patients with MGD
Exclusion criteria
Exclusion criteria: 1. atients who use dry eye or MGD treatment within 2 weeks before a study starts. 2. Patient who have a previous history of treatment intended to become obstructed lacrimal puncta. 3. Patients who need to use eyedrops other than test drugs during a study. 4. Patients who have anatomically and functionally abnormal eyelid. 5. Patients with surgical history in the internal eye (including laser therapy) within 3 months prior to initiation of the clinical research. 6. Patients who have a previous allergy to drugs that they use during a study. 7. Patients who have any other reasons that causes the study doctor to deem a subject unsuitable for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Symptoms 2. Slit lamp 3. Tear film breakup time 4. Meibography 5.Tear volume , Tear thickness | — |
Countries
Japan
Contacts
Public ContactShiro Amano
Inouye Eye Hospital Ophthalmology
Outcome results
None listed